Lundbeck and Otsuka’s Rexulti has become the first drug to be approved by the FDA to treat agitation associated with Alzheimer’s disease, a common symptom of the neurodegenerative disorder.
Analysts have suggested that approval for AAD could swell sales of Rexulti by $500 million to $1 billion, a big step up for a drug which currently ... At the Veeva Commercial Summit in Madrid ...
Danville Public Library is finding new ways to share knowledge and resources with the community. Three years after a native plant garden was installed at the library, visitors can now take home free ...
Various factors can lead an employer to institute pre-employment drug testing. Federal law requires some employees, such as commercial motor vehicle drivers, to pass a drug test before they are ...
While medication can provide symptom relief, it does not necessarily address underlying maladaptive behaviors, and is therefore considered by many clinicians and adjunct to treatment, rather than ...
Need to identify a tablet or capsule? Use our Pill Identifier to find the name and image of an unknown prescription or over-the-counter medication. Start by entering details like pill imprint code ...
How many commercial properties are listed for sale in Dubai? On Bayut, the number of currently listed commercial properties is 2,200. How much do the asking sale prices vary for commercial properties ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, some kinds of ...
What makes Horizon unique when it comes to business lending? Our Commercial Banking Advisors are dedicated to providing comprehensive support throughout the entire loan process.... Describe your ...